Curaizon™ is a London-based company that has developed CuraServe™, a solution to improve drug adherence and bring game-changing benefits to patients and healthcare providers. Our solution works with patients, their families and healthcare providers to ensure that patients take their medications as prescribed through a series of outreach tools, supported by predictive modeling and behavioral analysis tools to increase the rate of drug adherence. As our CuraServe™ solution helps patients, it’s also generating a vast amount of highly valuable patient data which is then anonymized and made available through our CuraData™ platform. Pharmaceutical companies, academics and non-profits can access this data by purchasing our CuraTokens™ (CTKN).
This is a $1.4 trillion problem and drug non-adherence is the 4th biggest killer worldwide. We will solve this and deliver improved patient outcomes, reduction of costs to healthcare providers and save hundreds of thousands of lives.
Our utility tokens are available to purchase for $0.20 and are backed by our data platform that will drive enormous value into the future.
We have a dedicated team that combines passion, innovation and expertise with experience in healthcare, finance, operations, marketing and technology.
Healthcare is changing forever and CuraServe™ stands at the cutting edge of this transformation.
To learn more about Curaizon and CuraToken:
This Press Release has been submitted by an ICL member.
materials in this post. Readers should do their own research before taking any actions related to the company. Initial Coin List is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or service.